The value of procalcitonin level in community-acquired pneumonia in the ED

American Journal of Emergency Medicine

Volumn 30, Issue 7, 2012, Pages 1248-1254

  Park, Jeong Ho ^a,b   Wee, Jung Hee ^a,b   Choi, Seung Pill ^a,b   Oh, Sang Hoon ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; ARTICLE; BACTEREMIA; BLOOD CULTURE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; EMERGENCY WARD; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE; KLEBSIELLA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; SURVIVOR; THORAX RADIOGRAPHY;

AGED; BIOLOGICAL MARKERS; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84865486381     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2011.08.009     Document Type: Article

References (25)

1. J.F. Michael, E.A. Thomas, M.Y. Donald, H.H. Barbara, A.W. Lisa, and E.S. Daniel A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250
2. W.D. Flanders, G. Tucker, A. Krishnadasan, D. Martin, E. Honig, and W.M. McClellan Validation of the pneumonia severity index J Gen Intern Med 14 1999 333 340
3. W.S. Lim, and J.T. Macfarlane Severity prediction rules in community acquired pneumonia: a validation study Thorax 55 2000 219 223
4. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Barlett, G.D. Campbell, and N.C. Dean Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults Clin Infect Dis 44 Suppl 2 2007 S27 S72
5. S. Ewig, T. Kleinfeld, T. Bauer, K. Seifert, H. Schafer, and N. Goke Comparative validation of prognostic rules for community acquired pneumonia in an elderly population Eur Respir J 14 2 1999 370 375
6. W.S. Lim, M.M. van der Eerden, R. Laing, W.G. Boersma, N. Karalus, and G.I. Town Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 5 2003 377 382
7. A. Capelastegui, P.P. Espana, J.M. Quintana, I. Areitio, I. Gorordo, and M. Ggurrola Validation of a predictive rule for the management of community-acquired pneumonia Eur Respir J 27 1 2006 151 157
8. S.M. Brown, B.E. Jones, A.R. Jephson, and N.C. Dean Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia Crit Care Med 37 12 2009 3010 3016
9. H. Ugarte, E. Silva, D. Mercan, A. De Mendonca, and J.L. Vincent Procalcitonin used as a marker of infection in the intensive care unit Crit Care Med 27 1999 498 504
10. B. Muller, K.L. Becker, H. Schachinger, P.R. Rickenbacher, P.R. Huber, and W. Zimmerli Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit Crit Care Med 28 2000 977 983
11. M. Masia, F. Gutierrez, C. Shum, S. Padilla, J.C. Navarro, and S. Flores Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index Chest 128 4 2005 2223 2229
12. N. Boussekey, O. Leroy, H. Georges, P. Devos, T. d'Escrivan, and B. Guery Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit Infection 33 4 2005 257 263
13. H.J. Heppner, T. Bertsch, B. Alver, A.S. Esslinger, C. Dragonas, and J.M. Bauer Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia-a clinical observation in geriatric patients Geronotology 56 4 2009 385 389
14. J.Y. Lee, S.J. Hwang, J.W. Shim, H.L. Jung, M.S. Park, and H.Y. Woo Clinical significance serum procalcitonin in patients with community-acquired lobar pneumonia Korean J Lab Med 30 4 2010 406 413
15. B. Muller, S. Harbarth, D. Stolz, R. Bingisser, C. Muller, and J. Leuppi Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia BMC Infect Dis 7 2007 10
16. S. Kruger, S. Ewig, R. Marre, J. Papassotiriou, K. Richter, and H. von Baum Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes Eur Respir J 31 2 2008 349 355
17. P. Schuetz, I. Suter-Widmer, A. Chaudri, M. Christ-Crain, W. Zimmerli, and B. Mueller Prognostic value of procalcitonin in community-acquired pneumonia Eur Respir J 37 2 2011 384 392
18. F. Hausfatar, S. Garric, S.B. Ayed, M. Rosenheim, M. Bernard, and B. Riou Usefulness of procalcitonin as a marker of systemic infection in emergency department patients; a prospective study Clin Infec Dis 34 7 2002 895 901
19. J. Hedlund, and L.O. Hansson C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis Infection 28 2 2000 68 73
20. A. Polzin, M. Pletz, R. Erbes, M. Raffenberg, H. Mauch, and S. Wagner Procalcitonin as a diagnostic tool in lower respiratory infections and tuberculosis Eur Respir J 21 6 2003 939 943
21. Y. Hirakata, K. Yanagihara, S. Kurihara, K. Izumikawa, M. Seki, and Y. Miyazaki Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia Diagn Microbiol Infect Dis 61 2 2008 170 174
22. R. Menendez, R. Martinez, S. Reyes, J. Mensa, X. Filella, and M.A. Marcos Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia Thorax 64 7 2009 587 591
23. M. Ugajin, S. Miwa, H. Ohba, T. Eifuku, H. Nakamura, and T. Suda Usefulness of serum procalcitonin levels in pulmonary tuberculosis Eur Respir J 37 2011 371 375
24. C. Chirouze, H. Schuhmacher, C. Rabaud, H. Gil, N. Khayat, and J.M. Estavoyer Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever Clin Infec Dis 35 2 2002 156 161
25. S. Liaudat, E. Dayer, G. Praz, J. Bille, and N. Troillet Usefulness of procalcitonin serum level for diagnosis of bacteremia Eur J Clin Microbiol Infect Dis 20 8 2001 524 527